Y-mAbs Therapeutics Inc (YMAB)
10.10
-0.44
(-4.17%)
USD |
NASDAQ |
Nov 21, 16:00
9.95
-0.15
(-1.49%)
Pre-Market: 08:07
Y-mAbs Therapeutics Gross Profit Margin (Quarterly): 87.82% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 87.82% |
| June 30, 2024 | 86.78% |
| March 31, 2024 | 89.23% |
| December 31, 2023 | 91.27% |
| September 30, 2023 | 87.07% |
| June 30, 2023 | 77.60% |
| March 31, 2023 | 89.71% |
| December 31, 2022 | 93.58% |
| Date | Value |
|---|---|
| September 30, 2022 | 80.26% |
| June 30, 2022 | 88.52% |
| March 31, 2022 | 82.54% |
| December 31, 2021 | 84.78% |
| September 30, 2021 | 93.86% |
| June 30, 2021 | 96.26% |
| March 31, 2021 | 98.27% |
| December 31, 2020 | 89.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
77.60%
Minimum
Jun 2023
98.27%
Maximum
Mar 2021
88.56%
Average
88.87%
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.45% |
| Return on Assets | -18.50% |
| Return on Invested Capital | -24.45% |
| Profit Margin (Quarterly) | -37.91% |
| Operating Margin (Quarterly) | -46.41% |
| Return on Net Operating Assets | -66.74% |